№ files_lp_3_process_9_24195
Regulatory toxicological study report presenting acute oral and dermal toxicity data, mortality findings, clinical observations and hazard classification outcomes for Abine (Abamectina 1.8% p/v) based on OECD-guided experiments in Wistar rats conducted in 2002.
Year: 2002
Product name: Abine (Abamectina 1.8% p/v)
Active substance: Abamectin
Study type: Acute oral toxicity study; Acute dermal toxicity study
Test guidelines: OECD No. 423; OECD No. 402
GLP compliance: Yes
Laboratory: Jai Research Foundation
Location: Valvada 396 108; Gujarat; India
Author: Aldrin Joseph, S.
Document numbers: JRF 3719; JFR 3720
Test species: Rat (Wistar)
Sex: Male and female
Route of administration: Oral (gavage); Dermal (semi-occlusive, 24 h)
Dose levels: 200, 500, 2000 mg/kg bw (oral); 2000 mg/kg bw (dermal)
Oral LD50: 500–2000 mg/kg bw
Dermal LD50: > 2000 mg/kg bw
Observation period: 14 days
Regulatory references: Directive 2001/59/EC; Regulation (EC) 1272/2008; Council Directive 67/548/EC
Hazard classification: R22 (Harmful if swallowed); H302 (Harmful if swallowed); H318 (Causes serious eye damage)
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.